Juvenile Idiopathic Arthritis (JIA) is the most common chronic rheumatic disease in childhood, affecting children and adolescents worldwide. It is characterized by persistent joint inflammation lasting for at least six weeks, with symptoms such as joint pain, swelling, stiffness, and limited mobility.
The prevalence of JIA varies across different populations and regions. However, studies estimate that JIA affects approximately 1 in every 1,000 children. It is important to note that JIA encompasses several subtypes, each with its own unique characteristics and prevalence rates.
JIA can have a significant impact on a child's quality of life, causing physical limitations, pain, and potential long-term complications. Early diagnosis and appropriate treatment are crucial in managing the disease and minimizing its impact on the affected individuals.
Research and medical advancements continue to improve our understanding of JIA, leading to better management strategies and improved outcomes for children living with this condition.